GALECTIN THERAPEUTICS INC. Proceeds from Related Party Debt
GALECTIN THERAPEUTICS INC. (GALT) reported Proceeds from Related Party Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2023-03-30
- GALECTIN THERAPEUTICS INC. proceeds from related party debt for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- GALECTIN THERAPEUTICS INC. proceeds from related party debt for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- GALECTIN THERAPEUTICS INC. proceeds from related party debt for the quarter ending 2021-12-31 was $10.00M.
- GALECTIN THERAPEUTICS INC. proceeds from related party debt for the quarter ending 2021-09-30 was $10.00M.
- GALECTIN THERAPEUTICS INC. proceeds from related party debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- GALECTIN THERAPEUTICS INC. proceeds from related party debt for fiscal 2021 was $30.00M.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 10-K · filed 2023-03-30 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |||
| 2021-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $20.00M derived: sum of 2 quarters · filed 2023-03-30 | $30.00M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $20.00M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $10.00M 10-Q · filed 2022-08-15 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |